Matti Kimberg

Matti was a molecular geneticist (University of Stellenbosch) and immunologist (University of Cape Town), with more than 10 years’ experience in regulated bioanalysis and clinical biomarkers.

As CSO, his primary focus was to ensure that the execution of all work performed at Synexa was scientifically driven by the objective of generating data that is informative towards answering the specific questions being asked in the context of each study. He had a deep understanding of the principals of the regulatory framework supporting bioanalysis and applying the guidelines provided by regulators to novel analytical technologies and therapeutic modalities.

Matti was passionate about using world class science and innovation to transform the way novel therapeutics are developed, to bring them to market faster, cheaper and safer.